| scholarly article | Q13442814 |
| P356 | DOI | 10.1200/JCO.2007.12.5641 |
| P698 | PubMed publication ID | 17947722 |
| P2093 | author name string | Denis C Talbot | |
| Henry Taylor | |||
| Pierre Ruffié | |||
| Liliane Ollivier | |||
| Gérard Dabouis | |||
| Jacques Margery | |||
| Marie-Claire Pinel | |||
| Alain Rivière | |||
| Graham Dark | |||
| Hélène Boussemart | |||
| Véronique Cadic | |||
| P433 | issue | 30 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 4751-4756 | |
| P577 | publication date | 2007-10-01 | |
| P1433 | published in | Journal of Clinical Oncology | Q400292 |
| P1476 | title | Phase II study of vinflunine in malignant pleural mesothelioma | |
| P478 | volume | 25 |
| Q42944291 | A Phase II Trial of Vinflunine As Monotherapy or in Combination with Trastuzumab as First-Line Treatment of Metastatic Breast Cancer |
| Q34336217 | A phase I evaluation of the combination of vinflunine and erlotinib in patients with refractory solid tumors |
| Q37716864 | Computer-aided volumetric assessment of malignant pleural mesothelioma on CT using a random walk-based method |
| Q37284023 | Critical evaluation of vinflunine in the treatment of refractory metastatic urothelial carcinoma |
| Q37449036 | Future developments in the management of malignant pleural mesothelioma |
| Q34293068 | Investigational approaches for mesothelioma |
| Q83412919 | Malignant pleural mesothelioma |
| Q37385373 | Novel anti-tubulin cytotoxic agents for breast cancer |
| Q30428531 | Phase I trial of vinflunine and pemetrexed in refractory solid tumors |
| Q37945636 | Raltitrexed in mesothelioma |
| Q37260408 | Systemic treatments for mesothelioma: standard and novel |
| Q37869505 | Vinflunine: drug safety evaluation of this novel synthetic vinca alkaloid |
| Q37768280 | Vinflunine: review of a new vinca alkaloid and its potential role in oncology |
| Q80426618 | [Malignant pleural mesothelioma: interrogations and hopes concerning the expected epidemic] |
Search more.